2m 2m 2m 2m 2m 2m 2m
Item 9 Labs (INLB)
OTC
$0.000001$0.00 (0.00%)
Price as of May 28, 2026- $102.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Item 9 Labs (INLB)
$0.000001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 40
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.000001
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume200,000
Market Cap$102.00
Shares Outstanding102.4M
P/E (TTM)-0.000003
Diluted EPS (TTM)-$0.31
Enterprise Value$72.0M
Information as of 05/28/2026
Company Profile
Item 9 Labs Corp.
https://www.item9labscorp.com$102.00
Market Cap
-$31.1M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
2727 North 3rd Street, Phoenix, AZ, United States, 85004
833 867 6337Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Key Executives
- Jeffrey I. Rassas
- Jayne Levy
- Mark Busch
- Cory Carter
- Kyle Jennings
Current Ownership Distribution
- Other665.6M (94.84%)
- Insiders36.2M (5.16%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)